Cardioversion in Acute Atrial Fibrillation Without Anticoagulation.

Area of Science:

• Cardiology
• Electrophysiology
• Thrombosis

Background:

• Cardioversion of acute atrial fibrillation poses a risk of thromboembolic events, primarily within the first week post-procedure.
• Transesophageal echocardiography reveals potential thrombus formation and spontaneous echo contrast in the left atrium and appendage.
• Atrial function may be impaired immediately after successful cardioversion, increasing event risk.

Purpose of the Study:

• To evaluate the thromboembolic risk associated with cardioversion of acute atrial fibrillation.
• To assess the impact of stroke risk factors on post-cardioversion thromboembolic events.
• To inform anticoagulation strategies following cardioversion.

Main Methods:

• Review of a large patient population undergoing cardioversion for acute atrial fibrillation.
• Analysis of thromboembolic event rates based on the presence or absence of classic stroke risk factors.
• Comparison of outcomes with and without anticoagulation therapy.

Main Results:

• Patients without stroke risk factors exhibited a low overall risk of thromboembolic events after cardioversion without anticoagulation.
• Patients with multiple classic stroke risk factors faced a significantly higher risk, around 10%.
• Current guidelines recommend anticoagulation for moderate-to-high risk patients.

Conclusions:

• Successful cardioversion of acute atrial fibrillation in low-risk patients may not require anticoagulation.
• Patients with multiple stroke risk factors remain at high risk and necessitate anticoagulation.
• Risk stratification is crucial for guiding anticoagulation decisions post-cardioversion.